rs4624820
From SNPedia
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | increased testicular cancer risk for men | |
(A;G) | 1.37x increased testicular cancer risk for men |
Make rs4624820(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 5 |
Position | 142302223 |
is a | snp |
is | mentioned by |
dbSNP | rs4624820 |
dbSNP (classic) | rs4624820 |
ClinGen | rs4624820 |
ebi | rs4624820 |
HLI | rs4624820 |
Exac | rs4624820 |
Gnomad | rs4624820 |
Varsome | rs4624820 |
LitVar | rs4624820 |
Map | rs4624820 |
PheGenI | rs4624820 |
Biobank | rs4624820 |
1000 genomes | rs4624820 |
hgdp | rs4624820 |
ensembl | rs4624820 |
geneview | rs4624820 |
scholar | rs4624820 |
rs4624820 | |
pharmgkb | rs4624820 |
gwascentral | rs4624820 |
openSNP | rs4624820 |
23andMe | rs4624820 |
SNPshot | rs4624820 |
SNPdbe | rs4624820 |
MSV3d | rs4624820 |
GWAS Ctlg | rs4624820 |
GMAF | 0.4844 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
23andMe blog each rs4624820(A) increases the odds of testicular cancer by 1.37x
GWAS snp | |
---|---|
PMID | [PMID 19483681] |
Trait | Testicular germ cell tumor |
Title | A genome-wide association study of testicular germ cell tumor |
Risk Allele | A |
P-val | 3E-13 |
Odds Ratio | 1.37 [1.19-1.58] |
GWAS snp | |
---|---|
PMID | [PMID 20543847] |
Trait | Testicular germ cell cancer |
Title | Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer |
Risk Allele | |
P-val | 1E-14 |
Odds Ratio | 1.47 [1.33-1.64] |
GWAS snp | |
---|---|
PMID | [PMID 23666239] |
Trait | Testicular germ cell tumor |
Title | Meta-analysis identifies four new loci associated with testicular germ cell tumor. |
Risk Allele | G |
P-val | 8E-10 |
Odds Ratio | 1.64 [1.39-1.89] |
GWAS snp | |
---|---|
PMID | [PMID 23666240] |
Trait | Testicular germ cell tumor |
Title | Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. |
Risk Allele | A |
P-val | 3E-31 |
Odds Ratio | 1.52 [1.38-1.67] |
[PMID 28295819] Variants in BAK1, SPRY4, and GAB2 are Associated with Pediatric Germ Cell Tumors: A Report from the Children's Oncology Group.